Table 3.
Multivariate analysis; anti-thrombopoietin (anti-TPO)-positive patients maintain lower platelet counts compared to anti-TPO negative patients (lower mean value −67·16 × 103/µl) after adjusting for other confounders (R2 0·56).
Variable | Coefficient§ | P-value | 95% CIs* |
---|---|---|---|
Anti-TPO (+ versus–) | − 67·16 | 0·002 | − 110·2 to −24·1 |
Corticosteroids (high versus low dose) | − 66·40 | 0·002 | − 108·0 to −24·7 |
IVIG (yes versus no) | − 105·54 | 0·000 | − 155·9 to −55·2 |
Cyclophosphamide (dose, mg) | − 0·02 | 0·377 | − 0·08 to 0·03 |
Antiphospholipid antibodies (+ versus–) | 75·56 | 0·000 | 35·3 to 115·8 |
Constant | 268·18 | 0·000 | 183·9 to 352·4 |
Positive, + negative, –
mean platelet difference (× 103/µl)
confidence intervals.